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Abstract: Modern China, similar to most developing nations, has seen a rise in the prevalence of both obesity and diesel exhaust 
based air pollution. The cause of obesity is multi-factorial encompassing diet, lifestyle and social factors. Also there has been a  
reduction in the consumption of fruit, vegetables, and traditional medicinal foods such as polyphenol containing green tea. Replacing
these, are high fat and carbohydrate based processed foods which are quickly displacing these wholefoods in the diet. This review 
paper proposes evidence that a potential cause of obesity is also linked to environmental stress stimuli such as air pollutants,  
particularly diesel exhaust fumes (DEF) of > 2.5 µm particulate matter, and discusses a role for a green tea catechin (EGCG) for use 
as a dietary defence against diet and environmentally induced obesity. China is now at a critical point of a public health pandemic 
with rising air-borne pollution (via car exhaust fumes DEF), industry pollution such as heavy metals, and the benzene hydrocarbon 
based ‘2PM’ particulate matter, now accepted as a major environmental issue for public health. Relevant data published in 
MEDLINE since 1995 has been gathered to formulate the following review. 
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1 Introduction 
Obesity is defined as the accumulation of adipose tissue 
caused by excessive dietary intake of calories or by the  
reduction of basal metabolic rate (BMR), or in part either in 
combination that presents a risk to the health of the individual1. 
The factors that influence obesity development, or modulation 
of BMR, appear numerous and highly complex. Modern China 
has seen a rise in the prevalence of obesity from as little as 
0.2% (1985) to 8.1% (2013), and is affecting males at a higher 
rate than females2. Although dietary patterns have changed, 
one factor sets China apart; the business of pollution. Pollution 
is being out-sourced to China by the West to mitigate tougher 
environmental laws and social unrest at a cost that is both seen 
and unseen, and literally ‘felt’ in China. Although industry is 
economically important, the people who drive the systems or 
live in proximity to industry are adversely affected, possibly 
impacting productivity. Pollution, in particular CO2 emissions, 
similar to wealth per capita, has increased exponentially in 
China over the past 25 years,  has now been linked to  
increased systemic inflammation as documented in a study in 
mice post-2008 Olympic games3. Further, a study of diesel 
fuel exhaust (DFE) affected maternal mice showed more obese 
male progeny4, linking DFE with inflammation and  
development of obesity.  
Traditionally herbs and food were seen as both disease  
preventative and pro-active medicinal agents in China, such as 
the use of Radix notoginseng for improving lipid profile5. 
However, with rising affluence, increased pollution, poor  
dietary choices through eating out, and sedentary behaviour, 
China can now ‘have its cake and eat it too’ with unseen  
association and costs impacting community health and negating
improved productivity. With worsening dietary habits in China, 
particularly in its youth, obesity in 12 to 18-year-olds boy has 
increased from 7.5%–12.5% from 2004 to 20096, appearing as 
one main influence for the development of obesity. Similar to 
this, there are a number of phytochemicals in food such as 
green tea (Camellia sinensis) studied, in particular the catechin 
EGCG which has been observed to display the most effective 
obesity protective effects, and yet despite this green tea’s  
consumption per capita is decreasing in China. It is literally a 
‘green paradox’. Green tea displays a multitude of health  
benefits, including a pronounced obesity protective role, which 
is linked in part to the presence of the phytochemical EGCG7. 
This review examines an established function of EGCG in a 
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new light; application in a seemingly unrelated two-facet public
health issue. 
Moreover, with the advancement of food technology and 
nutrition sciences in the 20th and 21st centuries, escalating time 
pressures due to urbanization has disenfranchised the largely 
agricultural labour workers of the Chinese populous of their 
traditional means of food production in peasant/community 
farms. Instead processed and ready to eat fast foods, as well as 
distribution centres in urban areas have largely displaced 
wholefoods such as fruit, vegetables, and herbs in the diet. In a 
parallel manner, there has been an increase in the prevalence 
of co-morbidities of obesity such as cardiovascular disease, as 
well as rise in the proximity of the populous to areas of  
diminished air quality. The obesity and diabetes protective 
effects of vegetables may be ascribed to their fiber content, 
reducing glycaemic load, or the phytochemicals and micro-
nutrients such as folate8, and possibly EGCG in green tea, 
however how the body reacts to environmental stress stimuli, 
in particular air and water pollution, may open a new paradigm 
on obesity and China’s economic development and health  
policies. Both a shift away from these natural dietary sources 
as well as the compounding effect of environmental stimulants 
that induce systemic inflammation, are key influences  
towards the development of obesity in a growing middle-class,  
urbanized China. 
As previously mentioned, a major factor influencing obesity 
development not widely explored is the role of airborne  
pollution on fat metabolism. Similar to most developing  
nations, China has seen an increase in environmental pollution, 
particularly airborne particles of < 2.5 µm in diameter, in cities 
such as Beijing, which have been documented to cause the 
reduction of pulmonary function (PF)9. A reduction in PF 
would reduce an individual’s ability for cardiovascular  
function, exercise, aerobic respiration, and cognitive function 
and directly influence body composition, and thus work  
capabilities. A reduction in aerobic respiration is linked to the 
development of obesity, and the individual’s inability to utilize 
fatty acids by the mitochondria skeletal muscle (SKM)  
decreases in efficiency and SKM as a percentage of body 
weight decrease10, further exacerbating obesity. Compounding 
this situation further is despite tea production in China  
increasing, its per capita tea consumption continues to decline. 
Thus, the anti-obesity and anti- inflammatory effects of  
consuming green tea may be exported to the West, whilst  
pollution is imported into China. Interestingly, air-pollution, in 
particular < 2.5 µm particulate matter has been linked to the 
development of obesity and inflammation in mice11. However, 
the link between dietary intake of black, red, Puer, or, green 
tea, either as a beverage, food and also medicinal agents and 
their relation to fat metabolism and possible therapeutic  
role with pollution induced obesity, remains to be further  
investigated. This review aims to propose this hypothesis with 
the support of in-vitro, animal and clinical trials.  
In addition to diet, lifestyle factors such as reduction in  
energy expenditure, disintegration of the family home, and 
occupational stress all contribute to modified behaviour, high-
er stress and a link with uncontrollable and compulsive eating 
behaviour which ultimately results in obesity12. Specifically, 
the reduction of dietary micronutrients such as secondary plant 
metabolites with their effect on fat and glucose metabolism in 
environmental induced obesity needs more research attention. 
 
1.1 Relationship of Lipid Droplets and Obesity: Obesity 
is defined as the accumulation and enlargement of adipocytes, 
and regionally reflected in increased visceral fat mass. This 
increased visceral fat mass is also associated with hepatic  
insulin resistance, type 2 diabetes and liver steatosis, with  
systemic inflammation a hallmark by the presence of cytokine 
hormones13. Lipid droplets are organelles, which contain a 
triacylglycerol (TAG) component used for energy storage, but 
the protein membrane surrounding the lipid contains proteins 
that act to communicate to the mitochondria for cellular energy
metabolism and fuel preferences14, and thus BMR. Further, 
EGCG affects lipid droplets size as a secondary outcome to the 
protection of cells from cell stress such as autophagy and thus 
reduce obesity indirectly15. EGCG presents as a natural  
phytochemical readily available in the diet of the Chinese 
populous that can ‘immunize’ against systemic inflammation 
cause by inhalation of excessive air-pollution, subsequent  
development of obesity, associated metabolic syndrome, and 
decreased labour force efficiency. 
 
1.2 Air Pollution and Induced Obesity: Recently, there 
has been growing research showing a link between the  
ingestion of air-pollution and the development of obesity. In a 
study of mature C57BL/CBA male mice, the researchers 
showed that inhalation of heavy industry pollution (steel mills) 
for a several days, especially the inhalation of < 2 µm  
particulate matter adsorbed with polycyclic aromatic  
hydrocarbons, stimulated LD formation in the lungs, possibly 
acting as a pollutant storage or cell signaller to induce reactive 
oxygen species (ROS) production, and in-turn endogenous 
antioxidant mechanisms16. Furthermore, prenatal DEF air  
pollution exposure in mice caused foetal brain cytokine  
response (systemic inflammation) and predisposed the male 
offspring to obesity. They also displayed increased anxiety, 
higher insulin levels (males only) and increased cerebral anti-
oxidant response via microglial activation displayed reduced 
physical activity (males) than their filtered air (FA) counter-
parts when they reached adulthood. Furthermore, in a  
longitudinal cohort study of mothers who gave birth to  
children born in certain New York boroughs between 1998–
2006, revealed that those who experienced higher polycyclic 
aromatic hydrocarbon (PAH) exposure, pre-disposed the  
children to a significantly higher body mass, and body fat for 
obesity at age 5 years, with a relative risk for obesity of 2.26 at 
the age of 7 years17. Moreover, Into et al.18, observed a  
relationship between a higher risk factor of child obesity and 
their respective maternal smoking habits during pregnancy. 
Thus, air-pollution, in the form of DE or cigarette exposure 
during pregnancy in mice or humans has shown to cause both 
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LD formation in response to increased systemic inflammation, 
but also adipocyte accumulation and obesity in their progeny. 
These findings are a major public health concern, particularly 
in countries where there is a high rate of DE based air  
pollution, and the involuntary inhalation of this pollution. 
 
1.3 China, Air Pollution and Inflammation: Beijing is 
commonly noted as one of the most polluted capital cities in 
Asia, and perhaps one of the top 10 most polluted capital cities 
in the world. Ambient fine particulate matter (diameters < 2.5 
μm; PM < 2.5) appears to be the main pollutant from car  
exhaust as well as industry. Increased air PM < 2.5 is linked to 
increased morbidity and mortality of cardiovascular diseases. 
This was evident in male C57BL/6 mice exposed to the  
Beijing PM < 2.5 air, two months following the Olympics. The 
mice displayed significant elevation of circulating monocyte 
chemo-attractant protein 1 in the lung and visceral fat of the 
mice. As mentioned earlier, this observation may be linked to 
the elevation of inflammatory cytokine interleukin 6 when 
compared with filtered air control mice. Phytochemicals in 
medicinal food and herbal medicine such as catechins in tea 
may prove to be effective to inhibit certain pathways related to 
cellular pollutant excretion and systemic inflammation, and be 
a useful dietary protectant to assist the Chinese populous to 
protect against systemic inflammation, obesity and pre-mature 
death due to cardiovascular disease. 
 
1.4 Phytochemical Relationship with Xenotoxin  
Excretion: Phytochemical have been shown to modify the 
excretion of pollutants such as DEF via multi-drug resistant 
transports such as p-glycoprotein (PgP)19. These toxins,  
pharmaceutical drugs and some phytochemicals from herbal 
extracts, are known as xenobiotics, and are metabolised via a 
specialized enzymatic system known as the phase enzymes. 
For example, the tracheal injection of DE particles such as 
quinoid or nitroaromatic structures, increases DNA damage 
via up-regulation of NADPH-cytochrome P450 reductase. 
Conversely, this up-regulation was reduced by endogens  
superoxide dismutase (SOD), and catalase enzyme activity20. 
Further, glutathione S-transferases are key enzymes which are 
important in the detoxification process, and are able to 
transport conjugated toxins following phase II processing  
outside of the cells21. The phenolic metabolites of benzene 
such as hydroquinone, catechol and 1,2,4-benzenetriol, may 
accumulate in fat tissue and subsequently be released upon 
ingestion of a lipolytic product such as EGCG in green tea. 
The direct elimination from cells of conjugated toxins is  
usually via the trans-membrane PgP22, with the elimination via 
the urine, bile etc., after processing. However, green tea does 
not seem to be responsible for the direct modulation of  
cytochrome P450 enzymes23, but may instead modulate the 
body composition in response to these xenotoxins, acting as a 
phytochemical protective mechanism against air-pollution 
induced obesity, chiefly ascribed to its anti-oxidant properties. 
 
2 Phytochemicals in Green Tea Responsible for Body 
Composition Modulating Effects - Catechins & Caffeine 
Green tea possesses a number of phytochemicals (see Table 
1 and Figures 1 & 2). One of those chemical groups is the 
catechins, or flavan-3-ol (flavanol), a secondary metabolite of 
the tea plant. The catechins commonly found in green tea  
include epigallocatechin (EGC), epicatechin (EC), epigallocat-
echin gallate (EGCG), and epicatechin gallate (ECG)24. Green 
tea also contains the methylxanthine, caffeine. 
 
3 Overview of Green Tea 
As shown in Table 1, the main phytochemicals present in 
green tea include hydrolysable tannins such as EGCG and also 
the methylxanthine caffeine. The polyphenol content of green 
tea has been suggested to reduce ROS such as reduction in 
lipid peroxidation in metabolic disorders such as obesity26. 
 
3.1 ROS Formation and Role of Anti-Oxidants: Reactive 
oxygen species are chemicals that contain oxygen, but are 
highly reactive oxygen such as O– and H2O2, natural by-
products of metabolism. Stress via dietary or environment 
influences can increase ROS production, leading to ‘oxidative 
stress’. Oxidative stress can manifest physically in a number of 
positive and negative ways; positive – apoptosis of undesirous 
cells (i.e. malignancies), platelets involved in wound repair, 
blood homeostasis, and in a negative way with ROS implicated
in a number of morbid conditions such as CHF, obesity and 
diabetes. Further, ROS causes DNA damage, oxidation of 
polyunsaturated fatty acids in the lipid membranes (lipid  
peroxidation) and the oxidation of amino acids in proteins. 
Certainly, it has been demonstrated that pre-pubescent children 
with excessive fat accumulation appear to induce higher levels 
of ROS, linking it to obesity27. SOD and catalyse are  
endogenous enzymes with anti-oxidant activity that modulate 
plasma ROS and are also increased in the ingestion of tracheal 
injected DE particles, as previously mentioned. EGCG is  
proposed as a phytochemical that protects against ROS  
formation by the excessive ingestion of air-pollution. 
 





Figure 2.  Caffeine 
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Fortunately, the body also has a number of endogens and 
exogenous defence systems to mitigate the harmful effects of 
ROS, including anti-oxidants. Anti-oxidants are a group of 
chemicals that protect against the deleterious effects of oxygen 
radicals. They include SOD, catalase, glutathione peroxidises 
(endogenous forms), and dietary forms; ascorbic acid,  
tocopherols and green tea polyphenols. In a study of human 
lymphocytes challenged with H2O2, in vitro pre-treatment with 
0.1% w/v green tea and also a parallel human trial (300 mL/d, 
6 weeks) of green tea reduced DNA damage28. Ingestion of 
air-pollution is a major environmental cause of systemic  
inflammation in urban populations or populations residing 
within the vicinity of factories in China. Green tea polyphenols
may provide the necessary ‘biological filtering’ needed to 
reduce oxidative stress, and associated increased incidence of 
obesity. Chinese food manufacturing needs to develop novel 
methods of ingesting green tea catechins in other beverages 
and food items is necessary in particular EGCG, and retain tea 
products for local consumption if they want to reduce the 
health burden of environmental pollution, obesity and  
associated economic costs of fatigue and reduced productivity 
per capita. The macroeconomic and health epidemiology 
analogy is to ‘sacrifice the golden goose to maintain the 
farm’s up-keep’. The multitude of morbid conditions such as 
cancer and cardiovascular disease, have ROS and systemic 
inflammation as hallmarks of their disease prognosis and are 
serious concerns for the ageing middle class. 
 
3.2 Relationship of Air-Borne Pollution and Increased 
Systemic Inflammation and Proposed Modulation by 
Green Tea Polyphenols: In a study by Chuang et al.29, the 
inhalation of particles with aerodynamic diameters i.e. < 2.5 
μm (2.5 PM), sulphate etc. models, were found to be correlated
with increases in inflammation C-reactive protein (CRP),  
8-OHdG), fibrogen, PAI-1 (inflammation, oxidation stress and 
blood coagulation respectively) and autonomic dysfunction 
simultaneously in healthy young humans, living in highly  
urbanized areas. Polyphenols found in green tea may present a 
natural method to control oxidative damage caused by the 
inhalation of air-borne pollutants and resultant in obesity  
development such as benzene hydrocarbons or its metabolites. 
Lowering ROS formation using dietary polyphenols such as 
EGCG may also decrease the incidence of obesity in urban 
pollutions subjected to high levels of air-pollution, as a  
secondary outcome of mitigating systemic inflammation. 
Green tea extracts have been noted to modulate ABC family 
transporter gene expression and protein function such as PgP 
and multidrug resistance-associated protein 2 (MRP2)30, and 
reversing multi-drug resistance in cancer cell lines. It was  
further revealed that EGCG down-regulated MDR1 gene  
expression and shows promise in drug resistant cancer  
treatment31. On the other hand, when exposed to DE  
fumes (DEF), P-glycoprotein, a trans-membrane multi-drug  
resistance protein is up-regulated in the blood-brain barrier 
during DEF ingestion. It ameliorates increased plasma TNF-α 
due to DEF, and reduces the inflammatory response due to 
oxidative stress. Further, Hartz et al. 2008 showed that pre-
treatment using radical scavengers such as EGCG, ameliorated 
DE-induced PgP up-regulation in capillaries, or the inhibition 
of NADPH oxidase, via inhibition of JNK and inhibition of 
cytokine induced apoptosis pathway, but not NF-κB pathway 
inhibition.  Moreover, green tea treatment has been suggested 
to be protective against oxidative damage caused by  
xenotoxins32 e.g. DEF, possibly via ABC transporters such as 
P-glycoprotein33. 
The relationship of EGCG and PgP in vivo may be synergis-
tic for the excretion of harmful air-pollutant toxins and their 
metabolites such as DEF, cigarette smoke (CS). EGCG has 
been shown to reduce lung morphological changes such as 
airspace enlargement and goblet cell hyperplasia; excessive 
mucus production and also oxidative stress in rats exposed to 
CS. The proposed mechanism is the suppression of CS-
induced oxidative stress34. The suppression of oxidative  
damage may be related to the reduction of systemic  
inflammation. At a molecular level, green tea polyphenols 
(GTP) (200 mg/Kg/d) have been shown, in conjunction with a 
high fructose diet, to reduce the detrimental effects of insulin 
signalling. Further, this GTP dosage modulates lipid  
metabolism and reduces inflammation in rat cardiac muscle35. 
The precise mechanisms proposed vary, but EGCG certainly 
reduces ROS and oxidative stress due to environmental  
influences such as air-pollution (i.e. DE) as depicted in  
Figure 3. 
 
3.3 Proposed Role of Green Tea Dietary Treatment of 
Oxidative Stress by Air-Borne Pollution Induced Obesity: 
Green tea compounds have been observed to display anti-
oxidants effects mainly via the up-regulation of the gene Nrf2, 
a primary cellular anti-oxidant defence against cytotoxic  
effects of oxidative stress, and protection against H2O2 induced 
Table 1. Outline of therapeutic action of green tea and active constituents 










Hydrolysable tannins: polyphenol 
(catechin), epigallocatechin gallate 
(EGCG); Methylxanthines: caffeine 
Flavanoids, Triterpenoid Saponins, 
Theanines, Theaflavins 
 anti-oxidant, astringent, anti-bacterial, anti-viral,  
hypo-cholesterolaemic, diuretic, anti-carcinogenic 
 Indicated in cancer, Alzheimer’s disease, cardiovascular 
disease. Modification of body composition (fat content), 
adjunct therapy in treatment of cancer, and hyper-
cholesterolaemia25. 
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apoptosis36. Green tea extract polyphenols also increase phase 
I and phase II enzyme activity in vivo37. Therefore, a diet rich 
in anti-oxidants such as EGCG is essential to reduce  
oxidant damage via ROS generation in phase I, in addition to  
consuming glutamic acid, cysteine and glycine containing 
foods, as liver GSH is an important endogenous anti-oxidant 38. 
In addition, theanine is a glutamate derivative found in tea, 
which has been observed to decrease the induction of the lipid 
peroxide and glutathione peroxidise. The mechanism was  
proposed as the inhibition of GSH reduction in the liver and 
heart39, with GSH showing a protective effect against benzene 
toxicity in gasoline pump workers40. The proposed mechanism 
by which green tea polyphenols as a group or specific phyto-
chemicals such as EGCG, and theanine, may attenuate the 
effect by GSH is to protect against DNA damage is by ROS. 
The formation of polyphenolic metabolites of benzene such 
as hydroquinone, catechol, 1,2,4-benzenetriol and pyrogallol, 
produce various ROS (namely H2O2, O2–, HO) causing DNA 
damage and reduction of GSH. This damage may be  
ameliorated by dietary consumption of GTP. However, phase 
II enzymes are elevated by both GTP and phenolic metabolites 
of benzene, whereas the GTP counterbalances the reduction of 
GSH, being especially antagonistic to the hydroxyl radical41. 
EGCG appears to effect hepatic detoxification enzymes, but 
also may be modified in vivo by intestinal bacteria, and hepatic 
conjugation to exert its effects as a conjugate. 
3.4 Absorption and Hepatic Modification of Green Tea 
via Hepatic Conjugation: Green tea catechins have been 
shown to be poorly absorbed in the small intestine, often post-
absorption, they are conjugated to glucuronic acid, sulphate 
groups etc., to leave a polyphenolic skeleton excreted in the 
urine42. Further, the effects of green tea catechins (total 85%) 
have been shown to influence the enzymatic system cyto-
chrome P450 oxidase (CYP) (P450 oxidases conjugates polar 
groups onto a xenotoxin), by both GTE and EGCG.  
Interestingly, both GTE and ECGC competitively inhibited 
CYP2B6 and CYP2C8 variants of CYP, and non-competitive 
inhibition against CYP3A in human liver microsomes, at  
concentrations of 5.9, 4.5, 48.7, 25.1 and 13.8 µg/mL  
respectively. In human intestinal microsomes, GTE and EGCG 
inhibited CYP3A at 18.4 µg/mL and 31.1 µM, respectively in 
a non-competitive manner. These results suggest that green tea 
catechins cause clinically relevant interactions with substrates 
for CYP2B6 and CYP2C8 in addition to CYP3A43. Hepatic 
inhibition of CYP450 enzymes may be linked with the  
reduction in systemic inflammation via reduced ROS  
formation, as toxins such as metabolites of benzene are  
conjugated in phase II reactions making them less volatile in 
the cell, and less likely to cause damage. Moreover, GTE has 
been shown in aflatoxin B1 challenge in pigs to enhanced  
glutathione S-transferase activity. GSH conjugates AFB1 to 
glutathione GSH in the intestine. Ultimately, AFB1 detoxifica-
tion is facilitated via cytochrome 450 enzyme activity in the 
 
Figure 3.  Diagrammatic summary, representing the hypothesized effect of DEF and 2PM pollution to induce systemic inflammation
and obesity. Further, EGCG is shown to reduce obesity (anti-obesity effect) and thus reduce adverse physiological effects of DEF, 
2PM pollution. Abbreviations not represented in the text: ↑ increase, ↓ decrease, rr: relative risk, TAG: Triacylglyceride. 
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liver and the enhancement of GST activity in the intestine44. 
Without the protective effects of GSH, benzene hydrocarbon 
pollution may continue to cause systemic inflammation and 
induced obesity in heavily polluted urban and city populations. 
 
3.5 Green Tea and Anti-Systemic Inflammatory Effect: 
Green tea consumption has been associated with a reduction in 
systemic inflammation. The inflammation inhibition effect of 
EGCG is well noted by the inhibition of nuclear factor-κB 
(NF-κB) pathway. NF-κB is a DNA transcription factor of 
many inflammatory mediators such as NOS2 and thus  
inhibiting NO production a known facilitator of cellular  
oxidative stress45. In a mouse model of polymicrobial sepsis, 
intraperitoneally injection of EGCG (10 mg/kg) ameliorated 
hypotension and increases the survival of mice with sepsis46. 
As previously mentioned, cigarette smoke increases oxidative 
stress, and inflammatory cellular responses. The dietary  
ingestion of green tea extract (3 mg/d, or 4.5 mg/d) increased 
the release of blood high mobility group box-1 (HMGB1) and 
elevated serum cotinine level, also confirmed in a murine  
macrophage cell lines47. Moreover, EGCG (dosage of 20 and 
40 mg/kg) has been observed to reduce systemic inflammation 
and oxidative stress as it inhibits tumour growth, reduced  
serum CRP, lipid peroxidation in mice bearing a solid Ehrlich 
ascites carcinoma48. In addition, a study of 24 female LEWIS 
rats, fed with chow and a 0.1% polyphenolic extracts from 
green tea were shown to reduce/ inhibit hepatic necrosis,  
oxidative stress (4-hydroxynonenal), IL-6 systemic cytokine 
release and apoptosis via caspase-8 and Bax, when rats were 
haemorrhaged via reduced plasma alanine aminotransferase 
and lactate dehydrogenase as well as down-regulation of both 
JNK and NFκB leading to reduced hepatic apoptosis49. 
The reduction in systemic inflammation by GTE in sepsis, 
tumour growth and hepatic necrosis may be a ubiquitous 
mechanism by which EGCG may reduce systemic inflamma-
tion, thus reduction of obesity by inhibition of adipocyte  
differentiation, decreased fatty acid synthase and increased 
lipolysis, and in summation a pronounced anti-obesity effect. 
The anti-inflammatory effects of EGCG as shown in these 
outlined disease states may also apply to inflammation cause 
by excessive ingestion of air-pollution, thus modulating the 
adverse effects of body composition modulation such as  
excessive accumulation of adipose tissue. 
 
3.6 Anti-Obesity and Body Composition Modulating  
Effect of EGCG: As previously mentioned, green tea, and 
more so EGCG and caffeine have well established anti-obesity 
actions both in vitro in cell culture and in vivo in animal and 
human models of obesity. In both animal and human studies, 
EGCG has been demonstrated to prevent the effects of genetic 
and diet induced obesity (DIO), insulin resistance and hyper-
tension, via reduced dietary fat absorption and metabolism 
modulation, increased glucose utilization, decreased de novo 
lipogenesis, and anti-oxidative effects50. Both the protective 
insulin resistance, hypotensive and hypocholesterolemic  
effects of EGCG are related to its overall anti-obesity effect 
via fat metabolism modulation. 
A mouse (C57BL/6J) and sprague dawley rat models of 
obesity using TEAVIGO tea extract (primarily EGCG)  
decreased sub-cutaneous and epididymal adipose tissue 
weights, plasma glucose, triglycerides, and leptin51. However, 
in a study of women with a BMI > 27 kg/m2 that consumed a 
supplement comprising of GTE of 400 mg [302 mg EGCG] 
thrice daily for 12 weeks, resulted in only a minor change of 
0.3% reduction in body weight, and respective reductions in 
LDL-cholesterol and triglyceride, with parallel increase in 
adiponectin and ghrelin suggesting increased β-oxidation and 
suppression of gluconeogenesis52. Limitations of the study 
include the lack of an exercise regime and also body  
composition analysis such as waist: hip ratio. It may be  
probable that the women may have increased muscle mass 
(thus fluid accumulation) and decreased adipose tissue with 
weight remaining stable. Interestingly, in a mouse model of 
diet induced obesity, 2% of a dietary sucrose substitution with 
Japanese green tea in a high sucrose (36.1%), high butter fat 
(38%) diet, significantly decreased total body fat, fatty liver, 
liver weight and also increased total muscle mass53, possibly 
via the EGCG content of the diet, as also observed by Bose et 
al.54 using a 3.2 g/kg of diet dosage in a high fat diet (60% 
energy as fat). Further, Basu et al. 2010 showed in a  
randomized human trial of obesity and metabolic syndrome, 
using a control group (4 cups water/d), or treatment; 4 cups of 
green/d) (treatment a), or green tea extract (2 capsules of either 
400 or 800 mg and 4 cups water/d) (treatment b) observed 
them for 8 weeks. All were matched for EGCG content except 
the control group. Both treatments (a) and (b) induced  
decreased body weight at 8 weeks, decreased LDL-cholesterol, 
decreased lipid peroxidation enzymes which correlated with 
plasma EGCG levels. Moreover, in postmenopausal women, 
supplementation of EGCG as a GTE reduced glucose, insulin 
and LDL-cholesterol with both 400 mg and 800 mg/d over a 
two months period. In a study using 0.5% dietary green tea 
polyphenols in a high-fat diet group for 4 months, was divided 
into two groups either consuming the GTP in the drinking 
water or food. Compared with the control high fat (HF) diet 
group, the GTP supplementation increased lean mass, bone 
mineral density and strength, and decreased pro-inflammatory 
cytokines and IGF-155. Furthermore, a decaffeinated green tea 
extract consisting of 530 mg total, containing 400 mg total 
catechins/capsule, was administered twice daily and was 
shown to decrease body weight versus placebo groups suggest-
ing a weight gain protective effect56. Direct decreased body 
weight by green tea catechins such as EGCG, in particular 
adipose tissue is a direct result of increased lipolysis, and  
decreased apipogenesis/lipogenesis, which may be a beneficial 
effect to reduce obesity development via increased systemic 
inflammation by inhalation of air-pollution and in combination 
with a rapidly changing diet in urbanized mainland Chinese. 
 
3.7 EGCG Induced Increased in Lipolysis, Decreased 
Adipogenesis: Lipolysis involves the catabolism of lipids into 
free fatty acids via triglyceride hydrolysis. They are transport 
in plasma by albumin protein and lipoproteins (VLDL, LDL, 
HDL) respectively. The next step known as β-oxidation  
degrades free fatty acids into acetyl-Co A which then enters 
the TCA cycle. 
In a two month dietary intervention of a human DIO trial, 
Yang et al.57 observed that daily consumption of a catechin 
rich tea (650 mL), reduced body weight by up to 20%, via 
increased lipolysis. WAT loss, specifically mediates a number 
of genes involved in adipogenesis, lipolysis, β-oxidation and 
thermogenesis in white adipose tissue (WAT)58. EGCG has 
been observed to also down-regulate adipogenesis genes such 
as peroxisome proliferator-activated receptor (PPAR)γ, fatty 
acid binding protein ((FABP)4), fatty acid synthase (FAS), 
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LPL, adiponectin etc59. In a male C57BL/6J mouse model fed 
a high-fat diet for 8 weeks induced obesity were then provided 
with dietary supplementation of 0.2 or 0.5% EGCG (w/w) for 
a further 8 weeks. This resulted in a reduction of body weight, 
adipose tissue mass, decreased plasma triglyceride and liver 
lipid. When examined for adipogenic genes the epididymal 
WAT the EGCG diet-fed mice displayed reduced adipogenic 
gene mRNA levels of PPAR-γ, LPL and FAS were  
significantly decreased. However, mRNA levels of carnitine 
palmitoyl transferase-1, uncoupling protein (UCP 2), hormone 
sensitive lipase (HSL) and adipose triglyceride lipase, were 
significantly increased. These results suggest that EGCG acts 
to increase energy metabolism, and lipolysis as mechanisms to 
decrease WAT in addition to its anti-inflammatory effect. 
As mentioned, ECGC decreases fatty acid synthesis. Fatty 
acid synthesis occurs via substrates such as acetyl-CoA and 
malonyl-CoA and the enzyme fatty acid synthases. In a study 
of MCF-7 breast cancer cells, Lin et al.60 observed the hypo-
lipidemic and anti-obesity effects of various teas including 
green tea are due to the inhibition of lipogenesis, in part due to 
down-regulated fatty acid synthase (FAS) mRNA expression, 
and up-regulation of energy expenditure in the mitochondria 
via protein kinase B)/Sp-1 signal transduction pathways  
(apoptosis pathway). Furthermore, another study examined the 
polyphenol effect from green tea, and gomchui tea (Ligularia 
fischeri) that all exhibit anti-obesity effects via inhibiting pan-
creatic lipase, in the following order; gomchui tea > coffee > 
green tea. EGCG was the most potent polyphenol to inhibit 
lipases however the di-O-caffeoylquinic acid isomers (DCQA) 
from gomchui tea were observed to be more stable during  
digestion. Thus, they displayed stronger lipase inhibitory  
activity during simulated digestion rather than EGCG61. 
Moreover, EGCG (20µM) has been observed to reduce 
Glycerol-3-Phosphate Dehydrogenase (GPDH) activity by 
50%, whereas other catechins inhibit GPDH at a concentration 
of > 100 uM. GPDH catalyzes the β-nicotinamide adenine 
dinucleotide (NADH)-dependent reduction of dihydroxyace-
tone phosphate (DHAP) to yield glycerol-3-phosphate, which 
serves as one of the major precursors of triacylglycerols62. 
Therefore, EGCG directly affects enzyme kinetics in fat  
synthesis directly effecting formation of the precursor mole-
cules. Both fatty acid and glucose metabolism dysfunction 
manifest as metabolic syndrome, with EGCG possibly being 
effective to reduce the severity of metabolic syndrome. Further, 
although lipase inhibitory is up-regulated by EGCG, fat mal-
absorption would explain part of its effect on modulating fat 
metabolism, and it may appear elusive where the metabolic 
energy of fat oxidation is being used, with non-digestive or 
non-shivering thermogenesis proving to be a likely candidate. 
Moreover, EGCG has been shown to decrease or even  
inhibit adipocyte differentiation. In a high fat diet model of 
obesity, TEAVIGO tea extract (primarily EGCG) was fed to 
mice (C57BL/6J) and Sprague-Dawley rats which resulted in 
decreased body weight (subcutaneous and epididymal adipose 
tissue weights), plasma glucose, triglycerides, and leptin,  
conferring with the inhibition of adipocyte differentiation in 
vitro, as evidenced by Wolfram et al. 2005. Furthermore, at a 
concentration of 10 µM, EGCG entirely inhibits adipocyte 
differentiation as evidenced in a mouse embryonic fibroblast-
adipose like cell line (3T3-L1)63. This observation may be only 
one mechanism by which EGCG ameliorates fatty liver via 
inhibition of adipocyte differentiation, and increased lipolysis. 
EGCG modulates fat metabolism by various mechanisms 
including malabsorption, increased lipolysis, decreased  
synthesis and adipocyte differentiation inhibition. Specifically, 
increased fatty acid lipolysis, requires further discussions to 
clarify key mechanisms to explain the apparent weight and fat 
loss, but may entail increased fatty acid oxidation and  
mitochondrial protein regulation.  Amelioration of fatty body 
composition induced by PM2 systemic inflammation is  
required to address the current health epidemic. 
 
3.8 EGCG Effect on Fatty Acid Oxidation and  
Thermogenesis: Fat oxidation or β-oxidation entails the  
degradation of fatty acids into acetyl-Co A sub-units which 
join the TCA cycle to produce ATP. β-oxidation occurs in the 
mitochondria and is increased in moderate exercise. Exercise 
maintained at 60% of maximal oxygen consumption 
(VO2max), with the consumption of 890 ± 13 mg green tea 
polyphenols, with 366 ±5 mg EGCG, versus a placebo diet of 
corn-flour (1729 ± 22 mg), increased fat oxidation rates by 
17% and in turn the proportion of energy expenditure due to 
fat oxidation increased in parallel with EGCG dosage64.  
Further, in a double blind placebo study EGCG supplementa-
tion with and without caffeine consumed for 3 days, increased 
fat oxidation within < 2hrs of a meal (+ 34.5%) and (+ 49.4%) 
respectively, and > 2hrs to increase postprandial fat oxidation 
(+ 26.3%) and (+ 35.4%) for the caffeine and EGCG/caffeine 
groups respectively. ECGC effects energy expenditure in 
combination with EGCG65. Further, in high fat-fed C57bl/6J 
mice treated with 0.32% dietary EGCG for 16 weeks, the mice 
displayed reduced body weight gain and final body weight 
(19.2% and 9.4% respectively) compared to high fat-fed  
controls, possibly via reduced insulin resistance by 33.9%. 
Further, EGCG reduced fatty liver, with increased skeletal 
muscle UCP3, and PPAR-α by 1.4-1.9-fold compared to high 
fat-fed controls. These genes are all related to mitochondrial 
fatty acid oxidation, with the mice also had increased faecal 
lipid content of faeces66, suggesting both fat malabsorption and 
increased fat oxidation. Fat oxidation may also concurrently 
work synergistically with the down-regulation of fatty acid 
synthesis enzymes in the liver and adipose tissue, with a cer-
tain percentage of fat malabsorbed and thus potential energy 
intake by-passed as the faeces. 
In a three month intervention trial of human DIO model of 
moderate obesity67 observed that green tea extract AR25 (25% 
catechins as EGCG), decreased body weight via increased 
thermogenesis. Also another proposed mechanism was the 
inhibition of gastric and pancreatic lipases, however this  
observation was not shared by Boschmann et al.68 who  
provided a 300 mg of EGCG/d for a short 2 d period. However, 
the limitations of this study were the small sample size (n = 6) 
and a short study duration of only 2 days, however other  
environmental factors such as temperature may also be  
involved in green tea (effect of EGCG and caffeine) induced 
thermogenesis. Moreover, during cold exposure (3hr exposure 
time), 1600 mg of EGCG and 600 mg of caffeine have been 
shown to effect non-shivering thermogenesis, reducing the 
shivering intensity by 20% and increase total AUC for energy 
expenditure by 10%69. It would appear the cycle of lipolysis 
and thermogenesis to be a steady state, but the physiological 
mechanisms governing EGCG effect on adipose tissue  
also may favour the concurrent inhibition of adipocyte  
differentiation. 
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Green tea has been observed to be beneficial for general 
obesity through a variety of mechanisms, but the reduction of 
inflammation, lipolysis, and inhibition of fatty acid synthesis 
and also adipocyte differentiation, seem to be likely candidates 
(see Figure 3). Results have emerged showing that EGCG and 
the EGCG free fractions regulate the gene expression of lipid 
metabolism enzymes, particularly the suppression of the  
lipogenic enzymes such as FAS, hydroxymethylglutaryl  
coenzyme A reductase, and acetyl-coenzyme A carboxylase 
α70. It is probable that this result was observed through other 
catechins and also the effect of caffeine in the non-EGCG 
water soluble fraction. Other lifestyle factors such as exercise 
may also potentiate both reduction in metabolic syndrome 
symptoms, reduced weight loss, increased lipolysis and hypo-
glycaemia in part or combination with dietary consumption of 
EGCG as a whole supplement or as a tea to ameliorate obesity. 
 
3.9 Exercise in Combination with EGCG Intake: Aerobic 
endurance exercise has been observed to increase fat utilization,
improve cardiovascular risk via reduced plasma cholesterol 
and improved glucose metabolism efficiency as evidenced by 
reduced HbA1c in type II patients71. Furthermore, the  
ingestion of a EGCG supplement (TEAVIGO) (150 mg twice 
daily) combined with exercise in overweight/obese postmeno-
pausal women exercised at moderate intensity for 12 weeks 
caused the reduction in total body fat, specifically reduction in 
waist circumference via reduction of abdominal fat, and  
intra-abdominal adipose tissue, possibly via a hypoglycaemic 
effect72. Furthermore, Venables et al. 2008 observed in healthy 
young men, that GTE ingestion (acute intake) can increase fat 
oxidation during a moderate exercise regime and is connected 
with glucose metabolism as insulin sensitivity is significantly 
improved. Moreover, in a 10 week double blinded placebo 
control) exercise program study, the ingestion of a caffeine-
EGCG-containing drink prior to exercise in overweight and 
obese women, significantly increased the muscle mass (MM), 
decreased total cholesterol with a significant time × training 
interaction for peak oxygen consumption observed. Further, 
there was a significant improvement in upper-body and lower-
body strength (p < 0.05), thus improving MM, fitness, and 
lipid profiles in overweight women73. Reduced pulmonary and 
cardiovascular function due to inhalation excessive air-
pollution may further compound an urbanized person’s ability 
to exercise, leading to accumulation of not only air-pollution 
toxins discussed but also but further development of fat  
accumulation, inflammation, and creation of a cyclic event that 
debilitates the individual in a perpetual state of oxidative stress. 
Another factor not suggested yet is appetite, one key variable 
affecting calorie intake with EGCG possibly causing satiety. 
Interestingly, in a study using a dietary supplement contain-
ing 170 mg of N-oleyl-phosphatidylethanolamine (NOPE) and 
100mg of EGCG were shown to improve patient compliance 
to low calorie diet during regular, and moderate exercise (for 
four weeks), but then failed thereafter for an additional 4 
weeks. Subjects reported experiencing fatigue and confusion 
however there was significant differences for body mass or 
composition74. Although fat metabolism appears to be the key 
area of body weight modulation, the shift in lipid utilization 
may be influenced by glucose metabolism. 
 
3.10 ECGC Effect on Glucose Metabolism: EGCG has 
been shown to influence glucose metabolism. In a two months 
trial administering 544 mg polyphenols and 456 mg as green 
tea catechins with the consumption of tea as a beverage, 
amounting to a total daily polyphenol content from tea and 
supplement amounting to 747 mg/day versus the 469 mg in the 
control group. There was a non-significant reduction in the 
body weight, and also BMI related to reduced plasma glucose 
and Hb A1c (glycated haemoglobin levels), whereas the  
reduction in insulin level was related to polyphenol content 
and HOMA index (β-cell function and insulin sensitivity index 
incorporating circulating pro-insulin)75, and in combination 
with exercise, EGCG intake for 12 weeks in exercising obese 
woman significantly reduced plasma glucose and also im-
paired GTT. EGCG on its own, possibly with the influence of 
caffeine, may induce hypoglycaemia, with a potentiated effect 
of exercise. Caffiene has been shown to be one of the main 
hypoglyceamic compounds in green tea, but appears to also 
impair insulin sensitivity76. 
Green tea polyphenols (GTE), in a study by Venables et al. 
2008, showed that healthy men consuming either a 890 ± 13 
mg of polyphenols and 366 ± 5 mg of EGCG per day or a  
placebo (corn-flour; 1729 ± 22 mg), provided for 24hrs prior 
to performing exercise (cycling 30 minutes; maintaining a 
60% of maximal oxygen consumption (VO2max), decreased 
insulin AUC with a parallel increase of 13% in insulin  
sensitivity. On the contrary, the supplementation of 400 mg 
capsules of EGCG twice daily in middle aged overweight and 
obese males subjects for an 8 week period revealed no effect 
on insulin sensitivity, secretion or glucose tolerance. The only 
result was a modest reduction in diastolic blood pressure and 
some improvement in mood77. This is further supported by 
Hsu et al. 201178, who reported green tea extract (856 mg of 
EGCG) did not affect anthropometric measurements, fasting 
glucose, haemoglobin A1C percentage (HbA1C), hormone 
peptides, or plasma lipoproteins in obese individuals with type 
2 diabetes. It appears that EGCG may affect insulin sensitivity 
in healthy males rather than type II diabetic middle aged males 
instead. The possible mechanism for insulin inhibition is via 
the effect of EGCG on adipose tissue, and to the pancreas via a 
secondary hormonal signaller. It was observed that the action 
of insulin was inhibited (by 50%) by EGCG directly (5–10 
µM) in 3T3-L1 and C3H10T1/2 adipocyte cell lines. Insulin 
stimulation of adipocytes was inhibited by EGCG in a dose/ 
time-dependent manner (2 h), thus inducing apoptosis, with 
other catechins/ phytochemicals effective in decreasing order; 
EGCG > EC> EGC > ECG. Adipocyte pre-treatment with the 
67LR antibody (67LR is an extracellular matrix glycoprotein, 
often up-regulated during certain forms of cancer), reversed 
the inhibition of insulin by EGCG, and thus the 67LR receptor 
may be one modulator of EGCG inhibited glucose absorption 
in adipogenesis79. Hseih et al.80 documented that EGCG exerts 
anti-insulin action via adipocyte glucose uptake via the AMPK, 
and that EGCG mediates lipolysis to render TAG available for 
β-oxidation. Further, EGCG down-regulates gluconeogenic 
enzymes such as glucose-6-phosphatase, phosphoenolpyruvate 
carboxykinase in mouse hepatocytes)81. Further, modulation of 
glucose and lipid metabolism by green tea, may also be in part 
due to modulation of adiponectin82, a hormone that increases 
β-oxidation and also suppresses gluconeogenesis. Hormones 
such as leptin, insulin and adiponectin may be pivotal to  
metabolic syndrome, glucose and fat metabolism dysfunction 
in obesity, with EGCG being a dietary supplement that has 
been shown to modulate the symptoms of metabolic syndrome. 
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3.11 EGCG Effect on Metabolic Syndrome: Metabolic 
syndrome (MtS), represents an array of symptoms ranging 
from increased blood pressure, hyperglycaemia, excess visceral
body fat, and fatigue. EGCG has been observed to ameliorate 
MtS. The male mice (C57BL/6J) were fed a high fat (HFW; 
60% as fat) diet, and compared with the HF group, the HFW 
group gain more body weight and also developed increase 
severity of metabolic syndrome (i.e. decreased BMR, fat  
accumulation and hypoglycaemia). Bose et al. 2008 proposed 
that EGCG treatment protects against both fat accumulation in 
body weight via increased faecal lipids, lower hepatic lipids, 
plasma cholesterol and hypoglycaemia, reduced insulin  
resistance and pro-inflammatory molecules such as CRP, IL-6, 
and granulocyte colony-stimulating factor (G-CSF). 
Ultimately, the dysfunction of lipid, glucose metabolism, 
with the development of metabolic syndrome and co-morbidity 
with CHF and cancer all cause of a shortened life span. EGCG 
may be one phytochemical that can modulate adipose tissue to 
improve both the quality of life and life span. Further,  
metabolic syndrome is associated with the up-regulation of 
lifespan determinant pathways (i.e. silent information regulator, 
SIR) T1, p66Shc, and mammalian target of rapamycin 
(TOR)83. It is associated with substrate availability and devel-
opment of visceral adipose tissue, insulin and IGF-1 levels, all 
of which have been observed to be modulated by EGCG. 
 
3.12 Green Tea, EGCG and Longevity – Influence of 
Obesity and Calorie Intake: Longevity is rather a subjective 
term as differs both for genders, different populations within 
and between countries have different life expectancy that  
determines a standard lifespan. Green tea has been shown to 
extend lifespan in lower organisms such as Caenorhabditis 
elegans, in particular the phytochemical theanine (conc. 100 
nM)84. Although green and black tea have been demonstrated 
to extend the life span of Caenorhabditis elegans, Drosophila 
and in some mouse models, in a study of male F1 hybrid mice 
and lifespan, it appeared green tea treatment had no effect. 
Interesting, in the same trial, a 40% calorically restricted diet 
induced extended lifespan. The green tea group did reduce 
body weight and fat, although the authors suggested that the 
polyphenol content does not contribute to longevity, even 
though the consumption of whole fruits and vegetables is  
associated with potentiated health and life span85. There may 
be several factors associated with higher fruit and vegetable 
consumption, such as lower calorie to nutrient ratio (nutrient 
dense foods increased fibre), and low calorie content due to 
the inherent water content (80–90%) which would aid satiety 
and restrict over-eating. Further, the fibre content of fruit and 
vegetables has been shown to modulate the absorption of  
carbohydrates (lower glyceamic index), and thus effect  
glucose metabolism (i.e. insulin sensitivity), as evidenced in a 
study examining the intake of a low GI soy based powder cake 
to suppress postprandial blood glucose but not insulin86. Lastly, 
higher fibre (β-glucan) lowers LDL cholesterol, a factor in the 
aetiology of heart disease, and thus a lower risk of a major 
morbidity factor in longevity, CHF. These effects may reduce 
morbid disease and improve quality of life leading to a longer 
life span, even in highly polluted cities.  Green tea included in 
food mould increase polyphenol and fibre content contributing 
to longevity. 
In agreement with these findings, green tea intervention for 
four months was shown in mice does not extend lifespan per 
se, however may reduce the risk of mid-life deaths in female 
mice87. Interestingly, in a human trial of middle aged Japanese 
men with hypertension (undergoing treatment) and also  
mitochondrial DNA 5178 cytosine/adenine (Mt5178C/A)  
polymorphism (associated with longevity). There was an  
association between Mt5178C genotype and hypertension 
which was found to be dependent on green tea consumption 
(lower odds ratio for hypertension)88. However, in mice who 
received 80mg/l in drinking water of green tea polyphenols 
displayed longer life spans (+ 6.5%) than their control  
counterparts89, possible due to EGCG content specifically. 
This effect was also seen in wild-type N2 and transgenic 
strains of Caenorhabditis elegans, due to regulation of  
intracellular levels of H2O2, which were inhibited by 220 µM 
EGCG, which extended the mean lifespan by 14.27 % in the 
FEM-1 (HC17) strain. Interestingly, under lethal oxidative 
stress, mean life span was increased specifically by 65.05%90. 
Unlike the study by Spindler et al. 2013, mice experienced 
stress, and suggested an important role for EGCG’s anti-
oxidant properties to extend life span, possibly via the up-
regulation of endogenous antioxidant enzymes, reducing  
inflammation, which could be useful as an inflammatory  
protectant against ingestion of excessive air-pollution. It may 
be that inclusion in food versus beverage may have a different 
effect. 
These external stresses may include dietary factors such as 
fat intake, but also air-pollution induced adipogenesis, and the 
formation of inflammatory molecules and enzymes such as 
superoxide (O2−), and lipid hydroperoxide (LPO) and the  
corresponding up-regulation of anti-oxidant enzymes such as 
SOD, which catalyze the dismutation of O2− into O2 and H2O2. 
Interestingly, one study showed that intake of dietary fat  
accelerates the ageing process via increase mortality in  
Drosophila melanogaster. The mechanism is thought to be via 
accumulating lipid hydroperoxide, when dietary fat was  
increased from 0–25%, which was partially reversed by green 
tea catechins in a 5% fat diet, and corresponding lowering of 
LPO. Inversely, catalase and SOD increased in the GTC or BE 
diet fed flies91. Given the multitude of positive aspects  
discussed, there may be inherent toxicities of green tea  
consumption related to its growing environment and need to 
be mentioned within this review to caution the reader to the 
consumption of some green tea grown in certain regions of 
China. 
 
3.13 Potential Toxicity Concerns of Green Tea Cultivated
in Polluted Areas: This paper has addressed mainly the pure 
form of EGCG, and not consumed in a tea leaf itself. Concerns 
regarding sourcing green tea cultivation in China and India, 
relate not only to air and soil pollution but also the use of 
harmful pesticides and herbicides. In a report by Harris et al.92, 
the authors suggested that the method of consumption of raw 
Chinese herbal medicines, that nearly 95% possessed levels of 
heavy metals or pesticides, with most safe for human  
consumption at levels detected. Further, the residue of  
hexachlorocyclohexane found in soil and water has been  
observed to accumulate in the roots, and leaves of teas plants 
in Fujian province, China93. Certainly the majority of  
registered tea companies are mandated by the government to 
conduct regular testing of tea products to ensure highest quality
and they meet certain national and international food standards. 
However, the origin of the tea and food safety GMP must be 
considered before considering inherent pollutants in the tea 
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that may be present due to environmental pollution during tea 
growth and post-harvest processing. 
 
4 Conclusions 
This article reviewed the role of green tea not only in  
traditional DIO, but also discussed its therapeutic use as a 
depurative and anti-oxidant in air-pollution exposure, in  
particular diesel exhaust induced obesity in both those exposed 
and their progeny. EGCG in it pure form and also in its  
traditional form in green tea with caffeine or novel green tea 
functional foods represent an effective and culturally acceptable
method in China to deliver a daily dietary treatment of both 
DIO, type 2 diabetes and also the ever increasing pandemic of 
air-pollution induced obesity (APIO). APIO is a new and 
growing threat to China’s public health from a respiratory, 
body composition and systemic inflammation perspective. The 
mechanisms of EGCG dietary modulation is multi-factorial but 
also presents an interesting target for the inhibition of  
air-pollution induced obesity. Further research needs to be  
conducted into the role of tea but also other herbal medicines 
currently un-investigated for their anti-inflammatory and  
depurative roles in both ameliorating the inflammatory effects 
of air-pollution and also the associated obesity protective  
effects. 
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distribution, and reproduction in any medium, provided the original 
author(s) and source are credited. 
 
References 
[1] Dulloo, A. G.; Montani, J. P. Obes. Rev. 2012, 13, 1–5. 
[2] Song, Y.; Wang, H. J.; Ma, J.; Wang, Z. PLoS One 2013, 8, 
e53069. 
[3] Xu, X.; Deng, F.; Guo, X.; Lv, P.; Zhong, M.; Liu, C.; Wang, A.; 
Tzan, K.; Jiang, S. Y.; Lippmann, M.; Rajagopalan, S.; Qu, Q.; 
Chen, L. C.; Sun, Q. Toxicol. Lett. 2012, 212, 20. 
[4] Bolton, J. L.; Smith, S. H.; Huff, N. C.; Gilmour, M. I.; Foster, W. 
M.; Auten, R. L.; Bilbo, S. D. FASEB J. 2012, 26, 474–454. 
[5] Xia, W.; Sun, C.; Zhao, Y.; Wu, L. Phytomedicine 2011, 18, 516–
520. 
[6] Seo, D. C.; Niu, J. Int. J. Behav. Med. 2013, Jun 7. 
[7] Suzuki, Y.; Miyoshim, N.; Isemura, M. Proc. Jpn. Acad. Ser. B 
Phys. Biol. Sci. 2012, 88, 88–101. 
[8] Bazzano, L. A.; Serdula, M. K.; Liu, S. Curr. Atheroscler. Rep. 
2003, 5, 492–499. 
[9] Wu, S.; Deng, F.; Hao, Y.; Shima, M.; Wang, X.; Zheng, C; Wei, 
H; Lv, H; Lu, X; Huang, J; Qin, Y; Guo, X. J. Hazard. Mater. 
2013, 260C, 183191. 
[10] Boyle, K. E.; Zheng, D.; Anderson, E. J.; Neufer, P. D.; 
Houmard, J. A. Int. J. Obes. (Lond) 2012, 36, 1025–1031. 
[11] Xu, X.; Yavar, Z.; Verdin, M.; Ying, Z.; Mihai, G.; Kampfrath, 
T.; Wang, A.; Zhong, M.; Lippmann, M.; Chen, L. C.; Ra-
jagopalan, S.; Sun, Q. Arterioscler. Thromb. Vase. Biol. 2010, 
30, 2518–2527. 
[12] Nevanperä, N. J.; Hopsu, L.; Kuosma, E.; Ukkola, O.; Uitti, J.; 
Laitinen, J. H. Am. J. Clin. Nutr. 2012, 95, 934–943. 
[13] Item, F.; Konrad, D. Obes. Rev. 2012, 13, 30–39. 
[14] Yang, L.; Ding, Y.; Chen, Y.; Zhang, S.; Hup, C.; Wang, Y.; Yu, 
J.; Zhang, P.; Na, H.; Zhang, H.; Ma, Y.; Liu, P. J. Lipid Res. 
2012, 53, 1245–1253. 
[15] Kim, H. S.; Montana, V.; Jang, H. J.; Parpura, V.; Kim, J. A. J. 
Biol. Chem. 2013, Jun 10. 
[16] Rowan-Carroll A.; Halappanavar, S.; Williams, A.; Somers, C. 
M.; Yauk, C. L. Environ. Mol. Mutagen. 2013, 54, 240–249. 
[17] Rundle, A.; Hoepner, L.; Hassoun, A.; Oberfield, S.; Freyer, G.; 
Holmes, D.; Reyes, M.; Quinn, J.; Camann, D.; Perera, F.; Why-
att, R. Am. J. Epidemiol. 2012, 175, 1163–1172. 
[18] Ino, T.; Shibuya, T.; Saito, K.; Inaba, Y. Int. J. Obes. (Lond) 
2012, 36, 554–558. 
[19] Hartz, A. M.; Bauer, B.; Block, M. L.; Hong, J. S.; Miller, D. S. 
FASEB J. 2008, 22, 2723–2733. 
[20] Kumagai, Y; Arimoto, T.; Shinyashiki, M; Shimojo, N; Nakai, 
Y.; Yoshikawa, T.; Sagai M. Free Radic. Biol. Med. 1997, 22, 
479–487. 
[21] Awasthi, Y. C.; Misra, G.; Rassin, D. K.; Srivastava, S. K. Br. J. 
Haematol. 1983, 55, 419–425. 
[22] Bolhuis, H.; van Veen, H. W.; Poolman, B.; Driessen, A. J. M.; 
Konings, W. N. FEMS Microbiol. Rev. 1997, 21, 55–84. 
[23] Chow, H. H.; Hakim, I. A.; Vining, D. R.; Crowell, J. A.; Cor-
dova, C. A.; Chew, W. M.; Xu, M. J., Hsu, C. H., Ranger-Moore, 
J., Alberts, D. S. Cancer Epidemiol. Biomarkers Prev. 2006, 15, 
2473–2476. 
[24] Peters, C. M.; Green, R. J.; Janle, E. M.; Ferruzzi, M. G. Food 
Res. Int. 2010, 43, 95–102. 
[25] Bone, K. (2007) Phytotherapy Press, Warwick, QLD, Australia. 
[26] Basu, A.; Sanchez, K.; Leyva, M. J.; Wu, M.; Betts, N. M.; As-
ton, C. E.; Lyons, T. J. J. Am. Coll. Nutr. 2010, 29, 31–40. 
[27] Faienza MF, F. R.; Goffredo, R.; Ventura, A.; Marzano, F.; 
Panzarino, G. Horm. Res. Paediatr. 2012, 78, 158–164. 
[28] Han, K. C.; Wong, W.; Benzie, I. F. Br. J. Nutr. 2011, 105, 171–
179. 
[29] Chuang, K. J.; Chan, C. C.; Su, T. C.; Lee, C. T.; Tang, C. S. Am. 
J. Resp. Crit. Care Med. 2011, 176, 370–376. 
[30] Netsch, M. I.; Gutmann, H.; Luescher, S.; Brill, S.; Schmidlin, C. 
B.; Kreuter, M. H.; Drewe, J. J. Planta Med. 2005, 71, 135–141. 
[31] Mei, Y.; Qian,. F.; Wei, D.; Liu, J. J. Pharm. Pharmacol. 2004, 
56, 1307–1314. 
[32] Geetanjali, K.; Santosh, S.; Naik. S. N. Mediterranean J. Nutr. 
Metab. 2011, 4, 11–31. 
[33] Coy, D. J. (2012). Theses and Dissertations – Toxiology. Paper 
4. http://unowledge.uky.edu/toxicology_etds/4.  
[34] Chan, K. H.; Ho, S. P.; Yeung, S. C.;So, W. H.; Cho, C. H.; Koo, 
M. W.; Lam, W. K.; Ip, M. S.; Man, R. Y.; Mak, J. C. Repir. 
Med. 2009, 103, 1746–1754. 
[35] Qin, B.; Polansky, M. M.; Harry, D.; Anderson, R. A. Mol. Nutr. 
Food Res. 2010, 54, 14–23. 
[36] Reuland, D. J.; Khademi, S.; Castle, C. J.; Irwin, D. C.; McCord, 
J. M., Miller, B. F.; Hamilton, K. L. Free Radic. Biol. Med. 2013, 
56, 102–111. 
[37] Akhlaghi, M.; Bandy, B. Nutr. Res. 2010, 30, 32–39. 
[38] Kaplowitz, N. Yale J. Biol. Med. 1981, 54, 497–502. 
[39] Sugiyama, T.; Sadzuka, Y. Cancer Lett. 2004, 212, 177–184. 
[40] Fracasso, M. E.; Doria, D.; Bartolucci, G. B.; Carrieri, M.; Lov-
reglio, P.; Ballini, A.; Soleo, L.; Tranfo, G.; Manno, M. Toxicol. 
Lett. 2010, 192, 22–28. 
[41] Lee, S. F.; Liang, Y. C.; Lin, J. K. Chem. Biol. Interact. 1995, 98, 
283–301. 
[42] Calani, L.; Dall'Asta, M.; Derlindati, E.; Scazzina, F.; Bruni, R.; 
Del Rio, D. J. Clin. Gastroenterol. 2012, 46, 95–99. 
[43] Misaka, S.; Kawabe, K.; Onoue, S.; Werba, J. P.; Giroli, M.; 
Tamaki, S.; Kan, T.; Kimura, J.; Watanabe, H.; Yamada, S. 
Drug Metab. Pharmacokinet. 2013, 28, 244–249. 
[44] Tulayakul, P.; Dong, K. S.; Li, J. Y.; Manabe, N.; Kumagai, S. 
Toxicon 2007, 50, 339–348. 
[45] Walker, M. W.; Kinter, M. T.; Roberts, R. J.; Spitz, D. R. Pedi-
atr. Res. 1995, 37, 41–49. 
[46] Wheeler, D. S.; Lahni, P. M.; Hake, P. W.; Denenberg, A. G.; 
Wong, H. R.; Snead, C.; Catravas, J. D., Zingarelli, B. Shock 
2007, 3, 353–359. 
[47] Saiwichai, T.; Sangalangkarn, V.; Kawahara, K.; Oyama, Y.; 
Chaichalotornkul, S.; Narkpinit, S.; Harnyuttanakorn, P.; 
Singhasivanon, P.; Maruyama, I.; Tancharoen, S. Southeast 
266      S. CICHELLO et al.                                                                                                                  Nat. Prod. Bioprospect. 2013, 3, 256–266 
 
         
Asian J. Trop. Med. Public Health 2010, 41, 250–258. 
[48] El-Mowafy, A. M.; Al.-Gayyar, M. M.; Salem, H. A.; El-Mesery, 
M. E.; Darweish, M. M. Phytomedicine 2010, 17, 1067–1075. 
[49] Relja, B.; Töttel, E.; Breig, L.; Henrich, D.; Schneider, H.; Marzi, 
I.; Lehnert M. Eur. J. Nutr. 2012, 51, 311–321. 
[50] Sae-tan, S.; Grove, K.; Lambert, J. D. Pharmacol. Res. 2011, 64, 
146–154. 
[51] Wolfram, S.; Raederstorff, D.; Wang, Y.; Teixeira, S. R.; Elste, 
V.; Weber, P. Ann. Nutr. Metab. 2005, 49, 54–63. 
[52] Hsu, C. H.; Tsai, T. H.; Kao, Y. H.; Hwang, K. C.; Teng, T. Y.; 
Chou, P. Clin. Nutr. 2008, 27, 363–370. 
[53] Cichello, S. A.; Begg, D. P.; Jois, M.; Weiseinger, R. S. Asia 
Pac. J. Clin. Nutr. 2007, 16, 48. 
[54] Bose, M.; Lambert, J. D.; Ju, J.; Reuhl, K. R.; Shapses, S. A.; 
Yang, C. S. J. Nutr. 2008, 138, 1677–1683. 
[55] Shen, C. L.; Cao, J. J.; Dagda, R. Y.; Chanjaplammootil, S.; Lu, 
C.; Chyu, M. C.; Gao, W.; Wang, J. S.; Yeh, J. K. Nutr. Res. 
2012, 32, 448–457. 
[56] Brown, A. L.; Lane, J.; Holyoak, C.; Nicol, B.; Mayes, A. E.; 
Dadd, T. Br. J. Nutr. 2011, 106, 1880–1889. 
[57] Yang, H. Y.; Wang, S. C.; Chao, J. C.; Chen, J. R. Br. J. Nutr. 
2012, 107, 749–754. 
[58] Lee, M. S.; Kim, C. T.; Kim, Y. Ann. Nutr. Metab. 2009, 54, 
151–157. 
[59] Lee, H.; Bae, S.; Yoon, Y. J. Nutr. Biochem. 2013, 24, 1232–
1240. 
[60] Lin, J. K.; Lin-Shiau, S. Y. Mol. Nutr. Food Res. 2006, 50, 211–
217. 
[61] Cha, K. H.; Song, D. G.; Kim, S. M.; Pan, C. H. J. Agri. Food 
Chem. 2012, 60, 7152–7157. 
[62] Kao, C. C.; Wu, B. T.; Tsuei, Y. W.; Shih, L. J.; Kuo, Y. L.; Kao, 
Y. H. Planta Med. 2010, 76, 694–696. 
[63] Chan, C. Y.; Wei, L.; Castro-Muñozledo, F.; Koo, W. L. Life Sci. 
2011, 89, 779–785. 
[64] Venables, M. C.; Hulsston, C. J.; Cox, H. R.; Jeukendrup, A. E. 
Am. J. Clin. Nutr. 2008, 87, 778–784. 
[65] Thielecke, F.; Rahn, G.; Bohnke, J.; Adams, F.; Birkenfeld, A. 
L.; Jordan, J.; Boschmann, M. Eur. J. Clin. Butr. 2010, 64, 704–
713. 
[66] Sae-Tan, S.; Grove, K. A.; Kennett, M. J.; Lambert, J. D. Food 
Funct. 2011, 2, 111–116. 
[67] Chantre, P.; Lairon, D. Phytomedicine 2002, 9, 3–8. 
[68] Boschmann, M.; Thielecke, F. J. Am. Coll. Nutr. 2007, 26, 389–
395. 
[69] Gosselin, C.; Haman, F. Br. J. Nutr. 2013, 110, 282–288. 
[70] Yasui, K.; Peng, N.; Miyoshi, N.; Suzuki, T.; Taguchi, K.; Ishi-
gami, Y.; Ishigami, Y.; Fukutomi, R.; Imai, S.; Isemura, M.; Na-
kayama, T. Biomed. Res. 2012, 33, 9–13. 
[71] Lambers, S.; Van Laethem, C.; Van Zcker, K.; Calders, P. Clin. 
Rehabil. 2008, 22, 483–492. 
[72] Hill, A. M.; Coates, A. M.; Buckley, J. D.; Ross, R.; Thielecke, 
F.; Howe, P. R. J. Am. Coll. Nutr. 2007, 26, 396–402. 
[73] Smith, A. E.; Lockwood, C. M.; Moon, J. R.; Kendall, K. L.; 
Fukuda, D. H.; Tobkin, S. E.; Cramer, J. T.; Stout, J. R. Appl. 
Physiol. Nutr. Metab. 2010, 35, 607–616. 
[74] Mangine, G. T; Gonzalez, A. M.; Wells, A. J.; McCormack, W. 
P.; Fragala, M. S.; Stout, J. R.; Hoffman, J. R. Lipids Health Dis. 
2012, 11, 127. 
[75] Fukino, Y.; Shimbo, M.; Aoki, N.; Okubo, T.; Iso, H. J. Nutr. 
Sci. Vitaminol (Tokyo) 2005, 51, 335–342. 
[76] Beaudoin, M. S.; Allen, B.; Mazzetti, G.; Sullivan, P. J.; Graham, 
T. E. Appl. Physiol. Nutr. Metab. 2013, 38, 140–147. 
[77] Brown, A. L.; Lane, J.; Coverly, J.; Stocks, J.; Jackson, S.; Ste-
phen, A.; Bluck, L.; Coward, A.; Hendrickx, H. Br. J. Nutr. 
2009, 101, 886–894. 
[78] Hsu, C. H.; Liao, Y. L.; Lin, S. C.; Tsai, T. H.; Huang, C. J.; 
Chou, P. Altern. Med. Rev. 2011, 16, 157–163. 
[79] Lin, J.; Della-Fera, M. A.; Baile, C. A. Obes. Res. 2005, 13, 
982–990. 
[80] Hsieh, C. F.; Tsuei, Y. W.; Liu, C. W.; Kao, C. C.; Shih, L. J.; 
Ho, L. T.; Wu, L. Y.; Wu, C. P.; Tsai, P. H.; Chang, H. H.; Ku, 
H. C.; Kao, Y. H. Planta Med. 2010 76, 1694–1698. 
[81] Yasui, K.; Tanabe, H.; Miyoshi, N.; Suzuki, T.; Goto, S.; 
Taguchi, K.; Ishigami, Y.; Paeng, N.; Fukutomi, R.; Imai, S.; 
Isemura, M. Biomed. Res. 2011, 32, 313–320. 
[82]de Oliveira, C.; de Mattos, A. B.; Silva, C. B.; Mota, J. F.; 
Zemdgs, J. C. Vitam. Horm. 2012, 90, 57–94. 
[83] Fadini, G. P.; Ceolotto, G.; Pagnin, E.; de Kreutzenberg, S.; 
Acagaro, A. Aging Cell 2011, 10, 10–17. 
[84] Zarse, K.; Jabin, S.; Ristow, M. Eur. J. Nutr. 2012, 51, 765–768. 
[85] Spindler, S. R.; Mote, P. L.; Flegal, J. M.; Teter, B. Rejuvenation 
Res. 2013, 16, 143–151. 
[86] Oku, T.; Nakamura, M.; Takasugi, A.; Hashiguchi-Isoguro, M.; 
Tanabe, K.; Nakamura, S. Int. J. Food Sci. Nutr. 2009, 60, 224–
231.  
[87] Strong, R.; Miller, R. A.; Astle, C. M.; Baur, J. A.; de Cabo, R.; 
Fernandez, E.; Guo, W.; Javors, M.; Kirkland, J. L.; Nelson, J. F.; 
Sinclair, D. A.; Teter, B.; Williams, D.; Zaveri, N.; Nadon, N. L.; 
Harrison, D. E. J. Gerontol. A Biol. Sci. Med. Sci. 2013 68, 6–16. 
[88] Kokaze, A.; Ishikawa, M.; Matsunaga, N.; Karita, K.; Yoshida, 
M.; Ohtsu, T.; Ochiai, H.; Shirasawa, T.; Saga, N.; Hoshino, H.; 
Takashima, Y. Hum. Biol. 2012, 84, 307–318 
[89] Kitani , K.; Osawa, T.; Yokozawa, T. Biogerontology 2007, 8, 
567–573. 
[90] Abbas, S.; Wink, M. Planta Med. 2009, 75, 216–221. 
[91] Li, Y. M.; Chan, H. Y.; Yao, X. Q.; Huang, Y.; Chen, Z. Y. J. 
Nutr. Biochem. 2008, 19, 376–383. 
[92] Harris, E. S.; Cao, S.; Littlefield, B. A.; Craycroft, J. A.; Schol-
ten, R.; Kaptchk, T.; Fu, Y.; Wang, W.; Liu, Y.; Chen, H.; Zhao, 
Z.; Clardy, J.; Woolf, A. D.; Eisenberg, D. M. Sci. Total Environ. 
2011, 409, 4297–4305. 
[93] Yi, Z.; Zheng, L.; Guo, P.; Bi, J. Ecotoxicol. Environ. Saf. 2013, 
91, 156–161. 
 
